共查询到20条相似文献,搜索用时 31 毫秒
1.
Hans Bakker Takuji Oka Angel Ashikov Ajit Yadav Monika Berger Nadia A. Rana Xiaomei Bai Yoshifumi Jigami Robert S. Haltiwanger Jeffrey D. Esko Rita Gerardy-Schahn 《The Journal of biological chemistry》2009,284(4):2576-2583
In mammals, xylose is found as the first sugar residue of the
tetrasaccharide
GlcAβ1-3Galβ1-3Galβ1-4Xylβ1-O-Ser, initiating the
formation of the glycosaminoglycans heparin/heparan sulfate and
chondroitin/dermatan sulfate. It is also found in the trisaccharide
Xylα1-3Xylα1-3Glcβ1-O-Ser on epidermal growth factor
repeats of proteins, such as Notch. UDP-xylose synthase (UXS), which catalyzes
the formation of the UDP-xylose substrate for the different
xylosyltransferases through decarboxylation of UDP-glucuronic acid, resides in
the endoplasmic reticulum and/or Golgi lumen. Since xylosylation takes place
in these organelles, no obvious requirement exists for membrane transport of
UDP-xylose. However, UDP-xylose transport across isolated Golgi membranes has
been documented, and we recently succeeded with the cloning of a human
UDP-xylose transporter (SLC25B4). Here we provide new evidence for a
functional role of UDP-xylose transport by characterization of a new Chinese
hamster ovary cell mutant, designated pgsI-208, that lacks UXS activity. The
mutant fails to initiate glycosaminoglycan synthesis and is not capable of
xylosylating Notch. Complementation was achieved by expression of a
cytoplasmic variant of UXS, which proves the existence of a functional Golgi
UDP-xylose transporter. A ∼200 fold increase of UDP-glucuronic acid
occurred in pgsI-208 cells, demonstrating a lack of UDP-xylose-mediated
control of the cytoplasmically localized UDP-glucose dehydrogenase in the
mutant. The data presented in this study suggest the bidirectional transport
of UDP-xylose across endoplasmic reticulum/Golgi membranes and its role in
controlling homeostasis of UDP-glucuronic acid and UDP-xylose production.Xylose is only known to occur in two different mammalian glycans. First,
xylose is the starting sugar residue of the common tetrasaccharide,
GlcAβ1,3Galβ1,3Galβ1,4Xylβ1-O-Ser, attached to
proteoglycan core proteins to initiate the biosynthesis of glycosaminoglycans
(GAGs)2
(1). Second, xylose is found in
the trisaccharide Xylα1,3Xylα1,3Glcβ1-O-Ser in
epidermal growth factor (EGF)-like repeats of proteins, such as blood
coagulation factors VII and IX
(2) and Notch
(3)
(Fig. 1). Two variants of
O-xylosyltransferases (XylT1 and XylT2) are responsible for the
initiation of glycosaminoglycan biosynthesis, which differ in terms of
acceptor specificity and tissue distribution
(4-7),
and two different enzymatic activities have been identified that catalyze
xylosylation of O-glucose residues added to EGF repeats
(8-10).
On Notch, O-glucose occurs on EGF repeats in a similar fashion as
O-fucose, which modifications have been shown to influence
ligand-mediated Notch signaling
(11-16).
Recently, rumi, the gene encoding the Notch
O-glucosyltransferase in Drosophila, has been identified,
and inactivation of the gene was found to cause a temperature-sensitive
Notch phenotype (17).
Although this finding clearly demonstrated that O-glucosylation is
essential for Notch signaling, the importance of xylosylation for Notch
functions remains ambiguous.Open in a separate windowFIGURE 1.UDP-xylose metabolism in mammalian cells. A, UDP-Xyl is
synthesized in two steps from UDP-Glc by the enzymes UGDH, forming UDP-GlcA,
and UXS, also referred to as UDP-glucuronic acid decarboxylase. UGDH is
inhibited by the product of the second enzyme, UDP-Xyl
(42). B, in mammals,
UDP-Xyl is synthesized within the lumen of the ER/Golgi, where it is substrate
for different xylosyltransferases incorporating xylose in the
glycosaminoglycan core (XylT1 and XylT2) or in O-glucose-linked
glycans. The nucleotide sugar transporter SLC35D1
(52) has been shown to
transport UDP-GlcA over the ER membrane and SLC35B4
(29) to transport UDP-Xyl over
the Golgi membrane. The function of this latter transporter is unclear.Several different Chinese hamster ovary (CHO) cell lines with defects in
GAG biosynthesis have been isolated by screening for reduced incorporation of
sulfate (18) and reduced
binding of fibroblast growth factor 2 (FGF-2)
(19,
20) and by direct selection
with FGF-2 conjugated to the plant cytotoxin saporin
(21). Isolated cells (called
pgs, for proteoglycan synthesis mutants)
(21) exhibited defects in
various stages of GAG biosynthesis, ranging from the initiating
xylosyltransferase to specific sulfation reactions
(18,
19,
21-25).
Mutants that affect overall GAG biosynthesis were shown to have a defect in
the assembly of the common core tetrasaccharide. Interestingly, these latter
mutants could be separated into clones in which GAG biosynthesis can be
restored by the external addition of xylosides as artificial primers and those
that cannot (18). The two
mutants belonging to the first group are pgsA-745 and pgsB-761. Although
pgs-745 is defective in XylT2
(4-6,
18), pgsB-761 exhibits a
defect in galactosyltransferase I (B4GalT7), the enzyme that catalyzes the
first step in the elongation of the xylosylated protein (25 (see
Fig. 1B). Restoration
of GAG biosynthesis in the latter mutant presumably occurs through a second
β1-4-galactosyltransferase, able to act on xylosides when provided at
high concentration but not on the endogenous protein-linked xylose.Here we describe the isolation of a third CHO cell line (pgsI-208) with the
xyloside-correctable phenotype. The mutant is deficient in UDP-xylose synthase
(UXS), also known as UDP-glucuronic acid decarboxylase. This enzyme catalyzes
the synthesis of UDP-Xyl, the common donor substrate for the different
xylosyltransferases, by decarboxylation of UDP-glucuronic acid. Importantly,
UXS in the animal cell is localized in the lumen of the ER and/or Golgi
(26-28),
superseding at first sight the need for the Golgi UDP-xylose transporter,
which has been recently cloned and characterized
(29). Using this cell variant,
experiments were designed that establish the functional significance of
UDP-Xyl transport with respect to UDP-glucuronic acid production and
xylosylation. 相似文献
2.
Leonard Kaysser Liane Lutsch Stefanie Siebenberg Emmanuel Wemakor Bernd Kammerer Bertolt Gust 《The Journal of biological chemistry》2009,284(22):14987-14996
Caprazamycins are potent anti-mycobacterial liponucleoside antibiotics
isolated from Streptomyces sp. MK730-62F2 and belong to the
translocase I inhibitor family. Their complex structure is derived from
5′-(β-O-aminoribosyl)-glycyluridine and comprises a unique
N-methyldiazepanone ring. The biosynthetic gene cluster has been
identified, cloned, and sequenced, representing the first gene cluster of a
translocase I inhibitor. Sequence analysis revealed the presence of 23 open
reading frames putatively involved in export, resistance, regulation, and
biosynthesis of the caprazamycins. Heterologous expression of the gene cluster
in Streptomyces coelicolor M512 led to the production of
non-glycosylated bioactive caprazamycin derivatives. A set of gene deletions
validated the boundaries of the cluster and inactivation of cpz21
resulted in the accumulation of novel simplified liponucleoside antibiotics
that lack the 3-methylglutaryl moiety. Therefore, Cpz21 is assigned to act as
an acyltransferase in caprazamycin biosynthesis. In vivo and in
silico analysis of the caprazamycin biosynthetic gene cluster allows a
first proposal of the biosynthetic pathway and provides insights into the
biosynthesis of related uridyl-antibiotics.Caprazamycins
(CPZs)2
(Fig. 1, 1) are
liponucleoside antibiotics isolated from a fermentation broth of
Streptomyces sp. MK730-62F2
(1,
2). They show excellent
activity in vitro against Gram-positive bacteria, in particular
against the genus Mycobacterium including Mycobacterium
intracellulare, Mycobacterium avium, and Mycobacterium
tuberculosis (3). In a
pulmonary mouse model with M. tuberculosis H37Rv, administration of
caprazamycin B exhibited a therapeutic effect but no significant toxicity
(4). Structural elucidation
(2) revealed a complex and
unique composition of elements the CPZs share only with the closely related
liposidomycins (LPMs, 2)
(5). The core skeleton is the
(+)-caprazol (5)
composed of an N-alkylated
5′-(β-O-aminoribosyl)-glycyluridine, also known from
FR-900493 (6)
(6) and the muraymycins
(7)
(7), which is cyclized to form
a rare diazepanone ring. Attached to the 3′″-OH are β-hydroxy
fatty acids of different chain length resulting in CPZs A–G
(1). They differ from
the LPMs in the absence of a sulfate group at the 2″-position of the
aminoribose and the presence of a permethylated l-rhamnose
β-glycosidically linked to the 3-methylglutaryl (3-MG) moiety.Open in a separate windowFIGURE 1.Nucleoside antibiotics of the translocase I inhibitor family.The LPMs have been shown to inhibit biosynthesis of the bacterial cell wall
by targeting the formation of lipid I
(8). The CPZs are expected to
act in the same way and are assigned to the growing number of translocase I
inhibitors that include other nucleoside antibiotics, like the tunicamycins
and mureidomycins (9). During
peptidoglycan formation, translocase I catalyzes the transfer of
UDP-MurNAc-pentapeptide to the undecaprenyl phosphate carrier to
generate lipid I (10). This
reaction is considered an unexploited and promising target for new
anti-infective drugs (11).Recent investigations indicate that the 3″-OH group
(12), the amino group of the
aminoribosyl-glycyluridine, and an intact uracil moiety
(13) are essential for the
inhibition of the Escherichia coli translocase I MraY. The chemical
synthesis of the (+)-caprazol
(5) was recently
accomplished (14), however,
this compound only shows weak antibacterial activity. In contrast, the
acylated compounds 3 and 4 exhibit strong growth inhibition of
mycobacteria, suggesting a potential role of the fatty acid side chain in
penetration of the bacterial cell
(15,
16). Apparently, the
acyl-caprazols (4)
represent the most simplified antibiotically active liponucleosides and a good
starting point for further optimization of this class of potential
therapeutics.Although chemical synthesis and biological activity of CPZs and LPMs has
been studied in some detail, their biosynthesis remains speculative and only
few data exists about the formation of other translocase I inhibitors
(17,
18). Nevertheless, we assume
that the CPZ biosynthetic pathway is partially similar to that of LPMs,
FR-90043 (6), and
muraymycins (7) and
presents a model for the comprehension and manipulation of liponucleoside
formation. Considering the unique structural features of the CPZs we also
expect some unusual biotransformations to be involved in the formation of,
e.g. the (+)-caprazol.Here we report the identification and analysis of the CPZ gene cluster, the
first cluster of a translocase I inhibitor. A set of gene disruption
experiments provide insights into the biosynthetic origin of the CPZs and
moreover, heterologous expression of the gene cluster allows the generation of
novel bioactive derivatives by pathway engineering. 相似文献
3.
Kelvin B. Luther Hermann Schindelin Robert S. Haltiwanger 《The Journal of biological chemistry》2009,284(5):3294-3305
The Notch receptor is critical for proper development where it orchestrates
numerous cell fate decisions. The Fringe family of
β1,3-N-acetylglucosaminyltransferases are regulators of this
pathway. Fringe enzymes add N-acetylglucosamine to O-linked
fucose on the epidermal growth factor repeats of Notch. Here we have analyzed
the reaction catalyzed by Lunatic Fringe (Lfng) in detail. A mutagenesis
strategy for Lfng was guided by a multiple sequence alignment of Fringe
proteins and solutions from docking an epidermal growth factor-like
O-fucose acceptor substrate onto a homology model of Lfng. We
targeted three main areas as follows: residues that could help resolve where
the fucose binds, residues in two conserved loops not observed in the
published structure of Manic Fringe, and residues predicted to be involved in
UDP-N-acetylglucosamine (UDP-GlcNAc) donor specificity. We utilized a
kinetic analysis of mutant enzyme activity toward the small molecule acceptor
substrate 4-nitrophenyl-α-l-fucopyranoside to judge their
effect on Lfng activity. Our results support the positioning of
O-fucose in a specific orientation to the catalytic residue. We also
found evidence that one loop closes off the active site coincident with, or
subsequent to, substrate binding. We propose a mechanism whereby the ordering
of this short loop may alter the conformation of the catalytic aspartate.
Finally, we identify several residues near the UDP-GlcNAc-binding site, which
are specifically permissive toward UDP-GlcNAc utilization.Defects in Notch signaling have been implicated in numerous human diseases,
including multiple sclerosis
(1), several forms of cancer
(2-4),
cerebral autosomal dominant arteriopathy with sub-cortical infarcts and
leukoencephalopathy (5), and
spondylocostal dysostosis
(SCD)3
(6-8).
The transmembrane Notch signaling receptor is activated by members of the DSL
(Delta, Serrate, Lag2) family of ligands
(9,
10). In the endoplasmic
reticulum, O-linked fucose glycans are added to the epidermal growth
factor-like (EGF) repeats of the Notch extracellular domain by protein
O-fucosyltransferase 1
(11-13).
These O-fucose monosaccharides can be elongated in the Golgi
apparatus by three highly conserved
β1,3-N-acetylglucosaminyltransferases of the Fringe family
(Lunatic (Lfng), Manic (Mfng), and Radical Fringe (Rfng) in mammals)
(14-16).
The formation of this GlcNAc-β1,3-Fuc-α1,
O-serine/threonine disaccharide is necessary and sufficient for
subsequent elongation to a tetrasaccharide
(15,
19), although elongation past
the disaccharide in Drosophila is not yet clear
(20,
21). Elongation of
O-fucose by Fringe is known to potentiate Notch signaling from Delta
ligands and inhibit signaling from Serrate ligands
(22). Delta ligands are termed
Delta-like (Delta-like1, -2, and -4) in mammals, and the homologs of Serrate
are known as Jagged (Jagged1 and -2) in mammals. The effects of Fringe on
Drosophila Notch can be recapitulated in Notch ligand in
vitro binding assays using purified components, suggesting that the
elongation of O-fucose by Fringe alters the binding of Notch to its
ligands (21). Although Fringe
also appears to alter Notch-ligand interactions in mammals, the effects of
elongation of the glycan past the O-fucose monosaccharide is more
complicated and appears to be cell type-, receptor-, and ligand-dependent (for
a recent review see Ref.
23).The Fringe enzymes catalyze the transfer of GlcNAc from the donor substrate
UDP-α-GlcNAc to the acceptor fucose, forming the GlcNAc-β1,3-Fuc
disaccharide
(14-16).
They belong to the GT-A-fold of inverting glycosyltransferases, which includes
N-acetylglucosaminyltransferase I and β1,4-galactosyltransferase
I (17,
18). The mechanism is presumed
to proceed through the abstraction of a proton from the acceptor substrate by
a catalytic base (Asp or Glu) in the active site. This creates a nucleophile
that attacks the anomeric carbon of the nucleotide-sugar donor, inverting its
configuration from α (on the nucleotide sugar) to β (in the
product) (24,
25). The enzyme then releases
the acceptor substrate modified with a disaccharide and UDP. The Mfng
structure (26) leaves little
doubt as to the identity of the catalytic residue, which in all likelihood is
aspartate 289 in mouse Lfng (we will use numbering for mouse Lunatic Fringe
throughout, unless otherwise stated). The structure of Mfng with UDP-GlcNAc
soaked into the crystals (26)
showed density only for the UDP portion of the nucleotide-sugar donor and no
density for two loops flanking either side of the active site. The presence of
flexible loops that become ordered upon substrate binding is a common
observation with glycosyltransferases in the GT-A fold family
(18,
25). Density for the entire
donor was observed in the structure of rabbit
N-acetylglucosaminyltransferase I
(27). In this case, ordering
of a previously disordered loop upon UDP-GlcNAc binding may have contributed
to increased stability of the donor. In the case of bovine
β1,4-galactosyltransferase I, a section of flexible random coil from the
apo-structure was observed to change its conformation to α-helical upon
donor substrate binding (28).
Both loops in Lfng are highly conserved, and we have mutated a number of
residues in each to test the hypothesis that they interact with the
substrates. The mutagenesis strategy was also guided by docking of an
EGF-O-fucose acceptor substrate into the active site of the Lfng
model as well as comparison of the Lfng model with a homology model of the
β1,3-glucosyltransferase (β3GlcT) that modifies O-fucose on
thrombospondin type 1 repeats
(29,
30). The β3GlcT is
predicted to be a GT-A fold enzyme related to the Fringe family
(17,
18,
29). 相似文献
4.
5.
6.
Benjamin E. L. Lauffer Stanford Chen Cristina Melero Tanja Kortemme Mark von Zastrow Gabriel A. Vargas 《The Journal of biological chemistry》2009,284(4):2448-2458
Many G protein-coupled receptors (GPCRs) recycle after agonist-induced
endocytosis by a sequence-dependent mechanism, which is distinct from default
membrane flow and remains poorly understood. Efficient recycling of the
β2-adrenergic receptor (β2AR) requires a C-terminal PDZ
(PSD-95/Discs Large/ZO-1) protein-binding determinant (PDZbd), an intact actin
cytoskeleton, and is regulated by the endosomal protein Hrs (hepatocyte growth
factor-regulated substrate). The PDZbd is thought to link receptors to actin
through a series of protein interaction modules present in NHERF/EBP50
(Na+/H+ exchanger 3 regulatory factor/ezrin-binding phosphoprotein
of 50 kDa) family and ERM (ezrin/radixin/moesin) family proteins. It is not
known, however, if such actin connectivity is sufficient to recapitulate the
natural features of sequence-dependent recycling. We addressed this question
using a receptor fusion approach based on the sufficiency of the PDZbd to
promote recycling when fused to a distinct GPCR, the δ-opioid receptor,
which normally recycles inefficiently in HEK293 cells. Modular domains
mediating actin connectivity promoted receptor recycling with similarly high
efficiency as the PDZbd itself, and recycling promoted by all of the domains
was actin-dependent. Regulation of receptor recycling by Hrs, however, was
conferred only by the PDZbd and not by downstream interaction modules. These
results suggest that actin connectivity is sufficient to mimic the core
recycling activity of a GPCR-linked PDZbd but not its cellular regulation.G protein-coupled receptors
(GPCRs)2 comprise the
largest family of transmembrane signaling receptors expressed in animals and
transduce a wide variety of physiological and pharmacological information.
While these receptors share a common 7-transmembrane-spanning topology,
structural differences between individual GPCR family members confer diverse
functional and regulatory properties
(1-4).
A fundamental mechanism of GPCR regulation involves agonist-induced
endocytosis of receptors via clathrin-coated pits
(4). Regulated endocytosis can
have multiple functional consequences, which are determined in part by the
specificity with which internalized receptors traffic via divergent downstream
membrane pathways
(5-7).Trafficking of internalized GPCRs to lysosomes, a major pathway traversed
by the δ-opioid receptor (δOR), contributes to proteolytic
down-regulation of receptor number and produces a prolonged attenuation of
subsequent cellular responsiveness to agonist
(8,
9). Trafficking of internalized
GPCRs via a rapid recycling pathway, a major route traversed by the
β2-adrenergic receptor (β2AR), restores the complement of functional
receptors present on the cell surface and promotes rapid recovery of cellular
signaling responsiveness (6,
10,
11). When co-expressed in the
same cells, the δOR and β2AR are efficiently sorted between these
divergent downstream membrane pathways, highlighting the occurrence of
specific molecular sorting of GPCRs after endocytosis
(12).Recycling of various integral membrane proteins can occur by default,
essentially by bulk membrane flow in the absence of lysosomal sorting
determinants (13). There is
increasing evidence that various GPCRs, such as the β2AR, require
distinct cytoplasmic determinants to recycle efficiently
(14). In addition to requiring
a cytoplasmic sorting determinant, sequence-dependent recycling of the
β2AR differs from default recycling in its dependence on an intact actin
cytoskeleton and its regulation by the conserved endosomal sorting protein Hrs
(hepatocyte growth factor receptor substrate)
(11,
14). Compared with the present
knowledge regarding protein complexes that mediate sorting of GPCRs to
lysosomes (15,
16), however, relatively
little is known about the biochemical basis of sequence-directed recycling or
its regulation.The β2AR-derived recycling sequence conforms to a canonical PDZ
(PSD-95/Discs Large/ZO-1) protein-binding determinant (henceforth called
PDZbd), and PDZ-mediated protein association(s) with this sequence appear to
be primarily responsible for its endocytic sorting activity
(17-20).
Fusion of this sequence to the cytoplasmic tail of the δOR effectively
re-routes endocytic trafficking of engineered receptors from lysosomal to
recycling pathways, establishing the sufficiency of the PDZbd to function as a
transplantable sorting determinant
(18). The β2AR-derived
PDZbd binds with relatively high specificity to the NHERF/EBP50 family of PDZ
proteins (21,
22). A well-established
biochemical function of NHERF/EBP50 family proteins is to associate integral
membrane proteins with actin-associated cytoskeletal elements. This is
achieved through a series of protein-interaction modules linking NHERF/EBP50
family proteins to ERM (ezrin-radixin-moesin) family proteins and, in turn, to
actin filaments
(23-26).
Such indirect actin connectivity is known to mediate other effects on plasma
membrane organization and function
(23), however, and NHERF/EBP50
family proteins can bind to additional proteins potentially important for
endocytic trafficking of receptors
(23,
25). Thus it remains unclear
if actin connectivity is itself sufficient to promote sequence-directed
recycling of GPCRs and, if so, if such connectivity recapitulates the normal
cellular regulation of sequence-dependent recycling. In the present study, we
took advantage of the modular nature of protein connectivity proposed to
mediate β2AR recycling
(24,
26), and extended the opioid
receptor fusion strategy used successfully for identifying diverse recycling
sequences in GPCRs
(27-29),
to address these fundamental questions.Here we show that the recycling activity of the β2AR-derived PDZbd can
be effectively bypassed by linking receptors to ERM family proteins in the
absence of the PDZbd itself. Further, we establish that the protein
connectivity network can be further simplified by fusing receptors to an
interaction module that binds directly to actin filaments. We found that
bypassing the PDZ-mediated interaction using either domain is sufficient to
mimic the ability of the PDZbd to promote efficient, actin-dependent recycling
of receptors. Hrs-dependent regulation, however, which is characteristic of
sequence-dependent recycling of wild-type receptors, was recapitulated only by
the fused PDZbd and not by the proposed downstream interaction modules. These
results support a relatively simple architecture of protein connectivity that
is sufficient to mimic the core recycling activity of the β2AR-derived
PDZbd, but not its characteristic cellular regulation. Given that an
increasing number of GPCRs have been shown to bind PDZ proteins that typically
link directly or indirectly to cytoskeletal elements
(17,
27,
30-32),
the present results also suggest that actin connectivity may represent a
common biochemical principle underlying sequence-dependent recycling of
various GPCRs. 相似文献
7.
Michael S. Friedman Sivan M. Oyserman Kurt D. Hankenson 《The Journal of biological chemistry》2009,284(21):14117-14125
Wnt11 signals through both canonical (β-catenin) and non-canonical
pathways and is up-regulated during osteoblast differentiation and fracture
healing. In these studies, we evaluated the role of Wnt11 during
osteoblastogenesis. Wnt11 overexpression in MC3T3E1 pre-osteoblasts increases
β-catenin accumulation and promotes bone morphogenetic protein
(BMP)-induced expression of alkaline phosphatase and mineralization. Wnt11
dramatically increases expression of the osteoblast-associated genes
Dmp1 (dentin matrix protein 1), Phex (phosphate-regulating
endopeptidase homolog), and Bsp (bone sialoprotein). Wnt11 also
increases expression of Rspo2 (R-spondin 2), a secreted factor known
to enhance Wnt signaling. Overexpression of Rspo2 is sufficient for increasing
Dmp1, Phex, and Bsp expression and promotes bone
morphogenetic protein-induced mineralization. Knockdown of Rspo2 abrogates
Wnt11-mediated osteoblast maturation. Antagonism of T-cell factor
(Tcf)/β-catenin signaling with dominant negative Tcf blocks
Wnt11-mediated expression of Dmp1, Phex, and Rspo2
and decreases mineralization. However, dominant negative Tcf fails to block
the osteogenic effects of Rspo2 overexpression. These studies show that Wnt11
signals through β-catenin, activating Rspo2 expression, which is
then required for Wnt11-mediated osteoblast maturation.Wnt signaling is a key regulator of osteoblast differentiation and
maturation. In mesenchymal stem cell lines, canonical Wnt signaling by Wnt10b
enhances osteoblast differentiation
(1). Canonical Wnt signaling
through β-catenin has also been shown to enhance the chondroinductive and
osteoinductive properties of
BMP22
(2,
3). During BMP2-induced
osteoblast differentiation of mesenchymal stem cell lines, cross-talk between
BMP and Wnt pathways converges through the interaction of Smad4 with
β-catenin (2).Canonical Wnt signaling is also critical for skeletal development and
homeostasis. During limb development, expression of Wnt3a in the apical
ectodermal ridge of limb buds maintains cells in a highly proliferative and
undifferentiated state (4,
5). Disruption of canonical Wnt
signaling in Lrp5/Lrp6 compound knock-out mice results in limb- and
digit-patterning defects (6).
Wnt signaling is also involved in the maintenance of post-natal bone mass.
Gain of function in the Wnt co-receptor Lrp5 leads to increased bone mass,
whereas loss of Lrp5 function is associated with decreased bone mass and
osteoporosis pseudoglioma syndrome
(7,
8). Mice with increased Wnt10b
expression have increased trabecular bone, whereas Wnt10b-deficient mice have
reduced trabecular bone (9).
Similarly, mice nullizygous for the Wnt antagonist sFrp1 have increased
trabecular bone accrual throughout adulthood
(10).Although canonical Wnt signaling regulates osteoblastogenesis and bone
formation, the profile of endogenous Wnts that play a role in osteoblast
differentiation and maturation is not well described. During development,
Wnt11 is expressed in the perichondrium and in the axial skeleton and sternum
(11). Wnt11 expression is
increased during glucocorticoid-induced osteogenesis
(12), indicating a potential
role for Wnt11 in osteoblast differentiation. Interestingly, Wnt11 activates
both β-catenin-dependent as well as β-catenin-independent signaling
pathways (13). Targeted
disruption of Wnt11 results in late embryonic/early post-natal death because
of cardiac dysfunction (14).
Although these mice have no reported skeletal developmental abnormalities,
early lethality obfuscates a detailed examination of post-natal skeletal
modeling and remodeling.In murine development, Wnt11 expression overlaps with the expression of
R-spondin 2 (Rspo2) in the apical ectodermal ridge
(11,
15). R-spondins are a novel
family of proteins that share structural features, including two conserved
cysteinerich furin-like domains and a thrombospondin type I repeat
(16). The four R-spondin
family members can activate canonical Wnt signaling
(15,
17–19).
Rspo3 interacts with Frizzled 8 and Lrp6 and enhances Wnt ligand signaling.
Rspo1 enhances Wnt signaling by interacting with Lrp6 and inhibiting
Dkk-mediated receptor internalization
(20). Rspo1 was also shown to
potentiate Wnt3a-mediated osteoblast differentiation
(21). Rspo2 knock-out
mice, which die at birth, have limb patterning defects associated with altered
β-catenin signaling
(22–24).
However, the role of Rspo2 in osteoblast differentiation and maturation
remains unclear.Herein we report that Wnt11 overexpression in MC3T3E1 pre-osteoblasts
activates β-catenin and augments BMP-induced osteoblast maturation and
mineralization. Wnt11 increases the expression of Rspo2.
Overexpression of Rspo2 in MC3T3E1 is sufficient for augmenting BMP-induced
osteoblast maturation and mineralization. Although antagonism of
Tcf/β-catenin signaling blocks the osteogenic effects of Wnt11, Rspo2
rescues this block, and knockdown of Rspo2 shows that it is required for
Wnt11-mediated osteoblast maturation and mineralization. These studies
identify both Wnt11 and Rspo2 as novel mediators of osteoblast maturation and
mineralization. 相似文献
8.
9.
Greg Brown Alexander Singer Vladimir V. Lunin Michael Proudfoot Tatiana Skarina Robert Flick Samvel Kochinyan Ruslan Sanishvili Andrzej Joachimiak Aled M. Edwards Alexei Savchenko Alexander F. Yakunin 《The Journal of biological chemistry》2009,284(6):3784-3792
Gluconeogenesis is an important metabolic pathway, which produces glucose
from noncarbohydrate precursors such as organic acids, fatty acids, amino
acids, or glycerol. Fructose-1,6-bisphosphatase, a key enzyme of
gluconeogenesis, is found in all organisms, and five different classes of
these enzymes have been identified. Here we demonstrate that Escherichia
coli has two class II fructose-1,6-bisphosphatases, GlpX and YggF, which
show different catalytic properties. We present the first crystal structure of
a class II fructose-1,6-bisphosphatase (GlpX) determined in a free state and
in the complex with a substrate (fructose 1,6-bisphosphate) or inhibitor
(phosphate). The crystal structure of the ligand-free GlpX revealed a compact,
globular shape with two α/β-sandwich domains. The core fold of GlpX
is structurally similar to that of Li+-sensitive phosphatases
implying that they have a common evolutionary origin and catalytic mechanism.
The structure of the GlpX complex with fructose 1,6-bisphosphate revealed that
the active site is located between two domains and accommodates several
conserved residues coordinating two metal ions and the substrate. The third
metal ion is bound to phosphate 6 of the substrate. Inorganic phosphate
strongly inhibited activity of both GlpX and YggF, and the crystal structure
of the GlpX complex with phosphate demonstrated that the inhibitor molecule
binds to the active site. Alanine replacement mutagenesis of GlpX identified
12 conserved residues important for activity and suggested that
Thr90 is the primary catalytic residue. Our data provide insight
into the molecular mechanisms of the substrate specificity and catalysis of
GlpX and other class II fructose-1,6-bisphosphatases.Fructose-1,6-bisphosphatase
(FBPase,2 EC
3.1.3.11), a key enzyme of gluconeogenesis, catalyzes the hydrolysis of
fructose 1,6-bisphosphate to form fructose 6-phosphate and orthophosphate. It
is the reverse of the reaction catalyzed by phosphofructokinase in glycolysis,
and the product, fructose 6-phosphate, is an important precursor in various
biosynthetic pathways (1). In
all organisms, gluconeogenesis is an important metabolic pathway that allows
the cells to synthesize glucose from noncarbohydrate precursors, such as
organic acids, amino acids, and glycerol. FBPases are members of the large
superfamily of lithium-sensitive phosphatases, which includes three families
of inositol phosphatases and FBPases (the phosphoesterase clan CL0171, 3167
sequences, Pfam data base). These enzymes show metal-dependent and
lithium-sensitive phosphomonoesterase activity and include inositol
polyphosphate 1-phosphatases, inositol monophosphatases (IMPases),
3′-phosphoadenosine 5′-phosphatases (PAPases), and enzymes acting
on both inositol 1,4-bisphosphate and PAP (PIPases)
(2). They possess a common
structural core with the active site lying between α+β and
α/β domains (3).
Li+-sensitive phosphatases are putative targets for lithium therapy
in the treatment of manic depressive patients
(4), whereas FBPases are
targets for the development of drugs for the treatment of noninsulin-dependent
diabetes (5,
6). In addition, FBPase is
required for virulence in Mycobacterium tuberculosis and
Leishmania major and plays an important role in the production of
lysine and glutamate by Corynebacterium glutamicum
(7,
8).Presently, five different classes of FBPases have been proposed based on
their amino acid sequences (FBPases I to V)
(9–11).
Eukaryotes contain only the FBPase I-type enzyme, but all five types exist in
various prokaryotes. Types I, II, and III are primarily in bacteria, type IV
in archaea (a bifunctional FBPase/inositol monophosphatase), and type V in
thermophilic prokaryotes from both domains
(11). Many organisms have more
than one FBPase, mostly the combination of types I + II or II + III, but no
bacterial genome has a combination of types I and III FBPases
(9). The type I FBPase is the
most widely distributed among living organisms and is the primary FBPase in
Escherichia coli, most bacteria, a few archaea, and all
eukaryotes (9,
11–15).
The type II FBPases are represented by the E. coli GlpX and FBPase
F-I from Synechocystis PCC6803
(9,
16); type III is represented
by the Bacillus subtilis FBPase
(17); type IV is represented
by the dual activity FBPases/inosine monophosphatases FbpA from Pyrococcus
furiosus (18), MJ0109
from Methanococcus jannaschii
(19), and AF2372 from
Archaeoglobus fulgidus
(20); and type V is
represented by the FBPases TK2164 from Pyrococcus
(Thermococcus) kodakaraensis and ST0318 from Sulfolobus
tokodai (10,
21).Three-dimensional structures of the type I (from pig kidney, spinach
chloroplasts, and E. coli), type IV (MJ0109 and AF2372), and type V
(ST0318) FBPases have been solved
(10,
11,
19,
20,
22,
23). FBPases I and IV and
inositol monophosphatases share a common sugar phosphatase fold organized in
five layered interleaved α-helices and β-sheets
(α-β-α-β-α)
(2,
19,
24). ST0318 (an FBPase V
enzyme) is composed of one domain with a completely different four-layer
α-β-β-α fold
(10). The FBPases from these
three classes (I, IV, and V) require divalent cations for activity
(Mg2+, Mn2+, or Zn2+), and their structures
have revealed the presence of three or four metal ions in the active site.E. coli has five Li+-sensitive phosphatases as follows:
CysQ (a PAPase), SuhB (an IMPase), Fbp (a FBPase I enzyme), GlpX (a FBPase
II), and YggF (an uncharacterized protein) (see the Pfam data base). CysQ is a
3′-phosphoadenosine 5′-phosphatase involved in the cysteine
biosynthesis pathway (25,
26), whereas SuhB is an
inositol monophosphatase (IMPase) that is also known as a suppressor of
temperature-sensitive growth phenotypes in E. coli
(27,
28). Fbp is required for
growth on gluconeogenic substrates and probably represents the main
gluconeogenic FBPase (12).
This enzyme has been characterized both biochemically and structurally and
shown to be inhibited by low concentrations of AMP (IC50 15
μm) (11,
29,
30). The E. coli
GlpX, a class II enzyme FBPase, has been shown to possess a
Mn2+-dependent FBPase activity
(9). The increased expression
of glpX from a multicopy plasmid complemented the Fbp-
phenotype; however, the glpX knock-out strain grew normally on
gluconeogenic substrates (succinate or glycerol)
(9).In this study, we present the first structure of a class II FBPase, the
E. coli GlpX, in a free state and in the complex with FBP + metals or
phosphate. We have demonstrated that the fold of GlpX is similar to that of
the lithium-sensitive phosphatases. We have identified the GlpX residues
important for activity and proposed a catalytic mechanism. We have also showed
that YggF is a third FBPase in E. coli, which has distinct catalytic
properties and is more sensitive than GlpX to the inhibition by lithium or
phosphate. 相似文献
10.
Cheuk-Lun Lee Poh-Choo Pang William S. B. Yeung Bérangère Tissot Maria Panico Terence T. H. Lao Ivan K. Chu Kai-Fai Lee Man-Kin Chung Kevin K. W. Lam Riitta Koistinen Hannu Koistinen Markku Sepp?l? Howard R. Morris Anne Dell Philip C. N. Chiu 《The Journal of biological chemistry》2009,284(22):15084-15096
Glycodelin is a human glycoprotein with four reported glycoforms, namely
glycodelin-A (GdA), glycodelin-F (GdF), glycodelin-C (GdC), and glycodelin-S
(GdS). These glycoforms have the same protein core and appear to differ in
their N-glycosylation. The glycosylation of GdA is completely
different from that of GdS. GdA inhibits proliferation and induces cell death
of T cells. However, the glycosylation and immunomodulating activities of GdF
and GdC are not known. This study aimed to use ultra-high sensitivity mass
spectrometry to compare the glycomes of GdA, GdC, and GdF and to study the
relationship between the immunological activity and glycosylation pattern
among glycodelin glycoforms. Using MALDI-TOF strategies, the glycoforms were
shown to contain an enormous diversity of bi-, tri-, and tetra-antennary
complex-type glycans carrying Galβ1–4GlcNAc (lacNAc) and/or
GalNAcβ1–4GlcNAc (lacdiNAc) antennae backbones with varying levels
of fucose and sialic acid substitution. Interestingly, they all carried a
family of Sda (NeuAcα2–3(GalNAcβ1–4)Gal)-containing
glycans, which were not identified in the earlier study because of less
sensitive methodologies used. Among the three glycodelins, GdA is the most
heavily sialylated. Virtually all the sialic acid on GdC is located on the Sda
antennae. With the exception of the Sda epitope, the GdC N-glycome
appears to be the asialylated counterpart of the GdA/GdF glycomes. Sialidase
activity, which may be responsible for transforming GdA/GdF to GdC, was
detected in cumulus cells. Both GdA and GdF inhibited the proliferation,
induced cell death, and suppressed interleukin-2 secretion of Jurkat cells and
peripheral blood mononuclear cells. In contrast, no immunosuppressive effect
was observed for GdS and GdC.Glycodelin is a member of the lipocalin family. It consists of 180 amino
acid residues (1) with two
sites of N-linked glycosylation. There are four reported glycodelin
isoforms, namely glycodelin-A (amniotic fluid isoform,
GdA),4 glycodelin-F
(follicular fluid, GdF), glycodelin-C (cumulus matrix, GdC) and glycodelin-S
(seminal plasma, GdS)
(2–5).
Among the four glycodelin isoforms, only the N-glycan structures of
GdA and GdS have been previously determined. This was achieved using fast atom
bombardment mass spectrometry
(6,
7). The glycan structures of
GdA and GdS are completely different. In GdA, the Asn-28 site carries high
mannose, hybrid, and complex-type structures, whereas the second Asn-63 site
is exclusively occupied by complex-type glycans
(6). The major non-reducing
epitopes characterized in the complex-type glycans are
Galβ1–4GlcNAc (lacNAc), GalNAcβ1–4GlcNAc (lacdiNAc),
NeuAcα2–6Galβ1–4GlcNAc (sialylated lacNAc),
NeuAcα2–6GalNAcβ1–4GlcNAc (sialylated lacdiNAc),
Galβ1–4(Fucα1–3)GlcNAc (Lewis-x), and
GalNAcβ1–4(Fucα1–3)GlcNAc (lacdiNAc analog of the blood
group substance Lewis-x) (6).
Many of these oligosaccharides are rare in other human glycoproteins. GdS
glycans are unusually fucose-rich, and the major complex type glycan
structures are bi-antennary glycans with Lewis-x and Lewis-y antennae.
Glycosylation of GdS is highly site-specific. Asn-28 contains only high
mannose structures, whereas Asn-63 contains only complex type glycans. More
than 80% of the complex glycans have 3–5 fucose residues/glycan, and
none of the glycans is sialylated, which is unusual for a secreted human
glycoprotein (7). The glycan
structures of GdF and GdC are not known, although they differ in
lectin-binding properties and isoelectric point from the other two glycodelin
isoforms (5).Glycans are involved in various intracellular, intercellular, and
cell-matrix recognition events
(8,
9). Glycosylation determines
the biological activities of the glycodelin isoforms
(2,
10). For example, both GdA and
GdF inhibit the spermatozoa-zona pellucida binding
(11) via fucosyltransferase-5
(12), but only the latter
inhibits progesterone-induced acrosome reaction, thus preventing a premature
acrosome reaction of the spermatozoa. There is evidence that cumulus cells can
convert exogenous GdA and -F to GdC, the physicochemical properties of which
suggest that it is differently glycosylated compared with GdA/F
(5). Moreover, GdC stimulated
spermatozoa-zona pellucida binding in a dose-dependent manner, and it
effectively displaced sperm-bound GdA and -F
(4,
5). GdS suppresses capacitation
probably via its inhibitory activity on cholesterol efflux from spermatozoa
(13).Except for the effects on fertilization, GdA is involved in fetomaternal
defense. This glycodelin isoform suppresses proliferation and induces
apoptosis of T cells (2) and
inhibits natural killer cell
(14) and B-cell
(15) activities. Glycosylation
is involved in the binding of GdA to receptors on T cells
(16). The sialic acid of GdA
contributes to the apoptotic activity in T cells
(17,
18) and binding to CD45, a
potential GdA receptor (16).
The importance of glycosylation in glycodelin is further shown by the absence
of immunosuppressive activities in GdS with different glycosylation
(18). The immunomodulating
activities of GdF and GdC are unknown.Our previous work showed that glycans are indispensable for the different
glycodelins to exhibit their binding activities and biological effects
(13,
19,
20). The present study aims to
identify the effect of all four glycodelin isoforms on lymphocyte viability,
cell death, and interleukin-2 (IL-2) secretion and to correlate these
bioactivities with their glycosylation patterns determined by mass
spectrometry. 相似文献
11.
12.
Zhemin Zhou Yoshiteru Hashimoto Michihiko Kobayashi 《The Journal of biological chemistry》2009,284(22):14930-14938
13.
Isabel Molina-Ortiz Rub��n A. Bartolom�� Pablo Hern��ndez-Varas Georgina P. Colo Joaquin Teixid�� 《The Journal of biological chemistry》2009,284(22):15147-15157
Melanoma cells express the chemokine receptor CXCR4 that confers high
invasiveness upon binding to its ligand CXCL12. Melanoma cells at initial
stages of the disease show reduction or loss of E-cadherin expression, but
recovery of its expression is frequently found at advanced phases. We
overexpressed E-cadherin in the highly invasive BRO lung metastatic cell
melanoma cell line to investigate whether it could influence CXCL12-promoted
cell invasion. Overexpression of E-cadherin led to defective invasion of
melanoma cells across Matrigel and type I collagen in response to CXCL12. A
decrease in individual cell migration directionality toward the chemokine and
reduced adhesion accounted for the impaired invasion. A p190RhoGAP-dependent
inhibition of RhoA activation was responsible for the impairment in
chemokine-stimulated E-cadherin melanoma transfectant invasion. Furthermore,
we show that p190RhoGAP and p120ctn associated predominantly on the plasma
membrane of cells overexpressing E-cadherin, and that E-cadherin-bound p120ctn
contributed to RhoA inactivation by favoring p190RhoGAP-RhoA association.
These results suggest that melanoma cells at advanced stages of the disease
could have reduced metastatic potency in response to chemotactic stimuli
compared with cells lacking E-cadherin, and the results indicate that
p190RhoGAP is a central molecule controlling melanoma cell invasion.Cadherins are a family of Ca2+-dependent adhesion molecules that
mediate cell-cell contacts and are expressed in most solid tissues providing a
tight control of morphogenesis
(1,
2). Classical cadherins, such
as epithelial (E) cadherin, are found in adherens junctions, forming core
protein complexes with β-catenin, α-catenin, and p120 catenin
(p120ctn). Both β-catenin and p120ctn directly interact with E-cadherin,
whereas α-catenin associates with the complex through its binding to
β-catenin, providing a link with the actin cytoskeleton
(1,
2). E-cadherin is frequently
lost or down-regulated in many human tumors, coincident with morphological
epithelial to mesenchymal transition and acquisition of invasiveness
(3-6).Although melanoma only accounts for 5% of skin cancers, when metastasis
starts, it is responsible for 80% of deaths from skin cancers
(7). Melanocytes express
E-cadherin
(8-10),
but melanoma cells at early radial growth phase show a large reduction in the
expression of this cadherin, and surprisingly, expression has been reported to
be partially recovered by vertical growth phase and metastatic melanoma cells
(9,
11,
12).Trafficking of cancer cells from primary tumor sites to intravasation into
blood circulation and later to extravasation to colonize distant organs
requires tightly regulated directional cues and cell migration and invasion
that are mediated by chemokines, growth factors, and adhesion molecules
(13). Solid tumor cells
express chemokine receptors that provide guidance of these cells to organs
where their chemokine ligands are expressed, constituting a homing model
resembling the one used by immune cells to exert their immune surveillance
functions (14). Most solid
cancer cells express CXCR4, a receptor for the chemokine CXCL12 (also called
SDF-1), which is expressed in lungs, bone marrow, and liver
(15). Expression of CXCR4 in
human melanoma has been detected in the vertical growth phase and on regional
lymph nodes, which correlated with poor prognosis and increased mortality
(16,
17). Previous in vivo
experiments have provided evidence supporting a crucial role for CXCR4 in the
metastasis of melanoma cells
(18).Rho GTPases control the dynamics of the actin cytoskeleton during cell
migration (19,
20). The activity of Rho
GTPases is tightly regulated by guanine-nucleotide exchange factors
(GEFs),4 which
stimulate exchange of bound GDP by GTP, and inhibited by GTPase-activating
proteins (GAPs), which promote GTP hydrolysis
(21,
22), whereas guanine
nucleotide dissociation inhibitors (GDIs) appear to mediate blocking of
spontaneous activation (23).
Therefore, cell migration is finely regulated by the balance between GEF, GAP,
and GDI activities on Rho GTPases. Involvement of Rho GTPases in cancer is
well documented (reviewed in Ref.
24), providing control of both
cell migration and growth. RhoA and RhoC are highly expressed in colon,
breast, and lung carcinoma
(25,
26), whereas overexpression of
RhoC in melanoma leads to enhancement of cell metastasis
(27). CXCL12 activates both
RhoA and Rac1 in melanoma cells, and both GTPases play key roles during
invasion toward this chemokine
(28,
29).Given the importance of the CXCL12-CXCR4 axis in melanoma cell invasion and
metastasis, in this study we have addressed the question of whether changes in
E-cadherin expression on melanoma cells might affect cell invasiveness. We
show here that overexpression of E-cadherin leads to impaired melanoma cell
invasion to CXCL12, and we provide mechanistic characterization accounting for
the decrease in invasion. 相似文献
14.
Christopher P. Gayer Lakshmi S. Chaturvedi Shouye Wang David H. Craig Thomas Flanigan Marc D. Basson 《The Journal of biological chemistry》2009,284(4):2001-2011
The intestinal epithelium is repetitively deformed by shear, peristalsis,
and villous motility. Such repetitive deformation stimulates the proliferation
of intestinal epithelial cells on collagen or laminin substrates via ERK, but
the upstream mediators of this effect are poorly understood. We hypothesized
that the phosphatidylinositol 3-kinase (PI3K)/AKT cascade mediates this
mitogenic effect. PI3K, AKT, and glycogen synthase kinase-3β
(GSK-3β) were phosphorylated by 10 cycles/min strain at an average 10%
deformation, and pharmacologic blockade of these molecules or reduction by
small interfering RNA (siRNA) prevented the mitogenic effect of strain in
Caco-2 or IEC-6 intestinal epithelial cells. Strain MAPK activation required
PI3K but not AKT. AKT isoform-specific siRNA transfection demonstrated that
AKT2 but not AKT1 is required for GSK-3β phosphorylation and the strain
mitogenic effect. Furthermore, overexpression of AKT1 or an AKT chimera
including the PH domain and hinge region of AKT2 and the catalytic domain and
C-tail of AKT1 prevented strain activation of GSK-3β, but overexpression
of AKT2 or a chimera including the PH domain and hinge region of AKT1 and the
catalytic domain and C-tail of AKT2 did not. These data delineate a role for
PI3K, AKT2, and GSK-3β in the mitogenic effect of strain. PI3K is
required for both ERK and AKT2 activation, whereas AKT2 is sequentially
required for GSK-3β. Furthermore, AKT2 specificity requires its catalytic
domain and tail region. Manipulating this pathway may prevent mucosal atrophy
and maintain the mucosal barrier in conditions such as ileus, sepsis, and
prolonged fasting when peristalsis and villous motility are decreased and the
mucosal barrier fails.Mechanical forces are part of the normal intestinal epithelial environment.
Numerous different forces deform these cells including shear stress from
endoluminal chyme, bowel peristalsis, and villous motility
(1,
2). During normal bowel
function the mucosa is subjected to injury that must be repaired to maintain
the mucosal barrier (3,
4). Deformation patterns of the
bowel are altered in conditions such as prolonged fasting, post-surgical
ileus, and sepsis states, resulting in profoundly reduced mucosal deformation.
When such states are prolonged, proliferation slows, the mucosa becomes
atrophic, and bacterial translocation may ensue as the mucosal barrier of the
gut breaks down
(5–7).In vitro, repetitive deformation is trophic for intestinal
epithelial cells (8) cultured
on type I or type IV collagen or laminin. Human Caco-2 intestinal epithelial
cells (9), non-transformed rat
IEC-6 intestinal epithelial cells
(10), and primary human
intestinal epithelial cells isolated from surgical specimens
(11) proliferate more rapidly
in response to cyclic strain
(12) unless substantial
quantities of fibronectin are added to the media or matrix
(11) to mimic the acute phase
reaction of acute or chronic inflammation and injury. Cyclic strain also
stimulates proliferation in HCT 116 colon cancer cells
(13) and differentiation of
Caco-2 cells cultured on a collagen substrate
(9). This phenomenon has also
been observed in vivo
(14). Thus, repetitive
deformation may help to maintain the normal homeostasis of the gut mucosa
under non-inflammatory conditions. Previous work in our laboratory has
implicated Src, focal adhesion kinase, and the mitogen-activated protein
kinase (MAPK)2
extracellular signal-related kinase (ERK) in the mitogenic effect of strain
(10). Although p38 is also
activated in Caco-2 cells subjected to cyclic strain on a collagen matrix, its
activity is not required for the mitogenic effect of strain
(12).Although often the PI3K/AKT pathway is thought of as a parallel pathway to
the MAPK, this is not always the case. Protein kinase C isoenzymes
differentially modulate thrombin effect on MAPK-dependent retinal pigment
epithelial cell (RPE) proliferation, and it has been shown that PI3K or AKT
inhibition prevented thrombin-induced ERK activation and RPE proliferation
(15).PI3K, AKT, and glycogen synthase kinase (GSK), a downstream target of AKT
(16), have been implemented in
intestinal epithelial cell proliferation in numerous cell systems not
involving strain
(17–19)
including uncontrolled proliferation in gastrointestinal cancers
(20–22).
Mechanical forces activate this pathway as well. PI3K and AKT are required for
increased extracellular pressure to stimulate colon cancer cell adhesion
(23), although the pathway by
which pressure stimulates colon cancer cells in suspension differs from the
response of adherent intestinal epithelial cells to repetitive deformation
(24), and GSK is not involved
in this effect.3
Repetitive strain also stimulates vascular endothelial cell proliferation via
PI3K and AKT (25,
26), whereas respiratory
strain stimulates angiogenic responses via PI3K
(27). We, therefore,
hypothesized that the PI3K/AKT/GSK axis would be involved in the mitogenic
effects of repetitive deformation on a collagen matrix.To test this hypothesis, we used the Flexcell apparatus to rhythmically
deform Caco-2 intestinal epithelial cells. IEC-6 cells were used to confirm
key results. A frequency of 10 cycles per min was used, which is similar in
order of magnitude to the frequency that the intestinal mucosa might be
deformed by peristalsis or villous motility in vivo
(28,
29). Mechanical forces such as
repetitive deformation are likely cell-type and frequency-specific, as
different cell types respond to different frequencies. Vascular endothelial
cells respond to frequencies of 60–80 cycles/min
(25), whereas intestinal
epithelial cells may actually decrease proliferation in response to
frequencies of 5 cycles/min
(30). We characterized PI3K,
AKT, and GSK phosphorylation with strain, blocked these molecules
pharmacologically or by siRNA, and delineated the specificity of the AKT
effect using isozyme-specific siRNA and transfection of AKT1/2 chimeras. We
also characterized the interaction of this pathway with the activation of ERK
by strain, which has previously been implicated in the mitogenic response
(12). 相似文献
15.
Yayoi Kamata Aya Taniguchi Mami Yamamoto Junko Nomura Kazuhiko Ishihara Hidenari Takahara Toshihiko Hibino Atsushi Takeda 《The Journal of biological chemistry》2009,284(19):12829-12836
Filaggrin is a component of the cornified cell envelope and the precursor
of free amino acids acting as a natural moisturizing factor in the stratum
corneum. Deimination is critical for the degradation of filaggrin into free
amino acids. In this study, we tried to identify the enzyme(s) responsible for
the cleavage of deiminated filaggrin in vitro. First, we investigated
citrulline aminopeptidase activity in the extract of newborn rat epidermis by
double layer fluorescent zymography and detected strong activity at neutral
pH. Monitoring the citrulline-releasing activity, we purified an enzyme of 280
kDa, comprised of six identical subunits of 48 kDa. The NH2
terminus of representative tryptic peptides perfectly matched the sequence of
rat bleomycin hydrolase (BH). The enzyme released various amino acids except
Pro from β-naphthylamide derivatives and hydrolyzed
citrulline-β-naphthylamide most effectively. Thus, to break down
deiminated filaggrin, another protease would be required. Among proteases
tested, calpain I degraded the deiminated filaggrin effectively into many
peptides of different mass on the matrix-assisted laser
desorption/ionization-time of flight mass spectrum. We confirmed that various
amino acids including citrulline were released by BH from those peptides. On
the other hand, caspase 14 degraded deiminated filaggrin into a few peptides
of limited mass. Immunohistochemical analysis of normal human skin revealed
co-localization of BH and filaggrin in the granular layer. Collectively, our
results suggest that BH is essential for the synthesis of natural moisturizing
factors and that calpain I would play a role as an upstream protease in the
degradation of filaggrin.The mammalian epidermal keratinocytes arise from proliferating basal cells
and move outward through a series of distinct differentiation events to form
the stratum corneum (1,
2). During this progressive
epidermal differentiation, keratinocytes express different proteins such as
keratins, profilaggrin/filaggrin, involucrin, small proline-rich proteins,
loricrin, cystatin A, and elafin, which form the cornified envelope of mature
corneocytes
(3–7).
Profilaggrin is synthesized as a large, extremely insoluble phosphoprotein
that consists of a unique NH2-terminal Ca2+-binding
protein of the S-100 family, linked to 10–20 tandem filaggrin monomer
repeats
(8–10).
Each individual filaggrin repeat is completely removed by proteolysis to
generate the mature filaggrin monomer (a molecular mass of 37 kDa in human).
Then, filaggrin is completely degraded in the uppermost layer of the stratum
corneum to produce a mixture of free and modified hygroscopic amino acids that
are important for maintaining epidermal hydration
(2,
11–13).
In addition, a number of proteins are subjected to various post-translational
modifications such as disulfide bonding, N-(γ-glutamyl)-lysine
isopeptide cross-linking, and deimination during the terminal differentiation
of epidermal keratinocytes (4,
6,
14,
15). Deimination is catalyzed
by peptidylarginine deiminase
(PAD),2 which converts
arginine to citrulline in proteins
(17–19).
The modification seems essential for the processing into free amino acids
including citrulline.Several proteases reportedly participate in the processing of profilaggrin.
Furin, a member of the proprotein convertase family, has been proposed to
cleave the NH2 terminus of profilaggrin, facilitating the release
of the NH2-terminal S-100 protein
(20,
21). In contrast, calpain I
and profilaggrin endopeptidase I (PEP-I) were implicated in the processing of
the linker regions between the filaggrin monomer repeats to generate the
filaggrin monomer
(22–25).
Recently, significant results regarding the conversion of profilaggrin to
filaggrin have been obtained with the knock-out of matriptase/MT-SP1,
prostasin/channel-activating serine protease 1/Prss 8, and caspase 14
in mice
(26–28).
These proteases were a key component of the profilaggrin-processing pathway in
terminal epidermal differentiation. However, although the signal initiating
the degradation of profilaggrin at a defined stage of the maturation of the
stratum corneum was found to be the water gradient within the stratum corneum
itself (11), the proteases for
the processing of filaggrin and/or the deiminated form into peptides following
the breakdown of these peptides to amino acids including citrulline remain
unknown.In this study, we have purified a novel aminopeptidase using a deiminated
substrate from rat skin homogenate and identified it as a neutral cysteine
protease, bleomycin hydrolase (BH). Furthermore, we investigated the
processing of the deiminated filaggrin by calpain I or caspase 14. Based on
these results, we proposed that calpain I participated preferentially in the
processing of deiminated filaggrin into peptides and then BH appeared
essential for the breakdown of the peptides into amino acids. 相似文献
16.
17.
Yiliang Chen Ting Cai Haojie Wang Zhichuan Li Elizabeth Loreaux Jerry B. Lingrel Zijian Xie 《The Journal of biological chemistry》2009,284(22):14881-14890
Recent studies have ascribed many non-pumping functions to the Na/K-ATPase.
We show here that graded knockdown of cellular Na/K-ATPase α1 subunit
produces a parallel decrease in both caveolin-1 and cholesterol in light
fractions of LLC-PK1 cell lysates. This observation is further substantiated
by imaging analyses, showing redistribution of cholesterol from the plasma
membrane to intracellular compartments in the knockdown cells. Moreover, this
regulation is confirmed in α1+/– mouse liver.
Functionally, the knockdown-induced redistribution appears to affect the
cholesterol sensing in the endoplasmic reticulum, because it activates the
sterol regulatory element-binding protein pathway and increases expression of
hydroxymethylglutaryl-CoA reductase and low density lipoprotein receptor in
the liver. Consistently, we detect a modest increase in hepatic cholesterol as
well as a reduction in the plasma cholesterol. Mechanistically,
α1+/– livers show increases in cellular Src and ERK
activity and redistribution of caveolin-1. Although activation of Src is not
required in Na/K-ATPase-mediated regulation of cholesterol distribution, the
interaction between the Na/K-ATPase and caveolin-1 is important for this
regulation. Taken together, our new findings demonstrate a novel function of
the Na/K-ATPase in control of the plasma membrane cholesterol distribution.
Moreover, the data also suggest that the plasma membrane
Na/K-ATPase-caveolin-1 interaction may represent an important sensing
mechanism by which the cells regulate the sterol regulatory element-binding
protein pathway.The Na/K-ATPase, also called the sodium pump, is an ion transporter that
mediates active transport of Na+ and K+ across the
plasma membrane by hydrolyzing ATP
(1,
2). The functional sodium pump
is mainly composed of α and β subunits. The α subunit is the
catalytic component of the holoenzyme; it contains both the nucleotide and the
cation binding sites (3). So
far, four isoforms of α subunit have been discovered, and each one shows
a distinct tissue distribution pattern
(4,
5). Interestingly, studies
during the past few years have uncovered many non-pumping functions of
Na/K-ATPase
(6–10).
Recently, we have demonstrated that more than half of the Na/K-ATPase may
actually perform cellular functions other than ion pumping at least in LLC-PK1
cells (11). Moreover, the
non-pumping pool of Na/K-ATPase mainly resides in caveolae and interacts with
a variety of proteins such as Src, inositol 1,4,5-trisphosphate receptor, and
caveolin-1
(12–14).
While the interaction between Na/K-ATPase and inositol 1,4,5-trisphosphate
receptor facilitates Ca2+ signaling
(13) the dynamic association
between Na/K-ATPase and Src appears to be an essential step for ouabain to
stimulate cellular kinases
(15). More recently, we report
that the interaction between the Na/K-ATPase and caveolin-1 plays an important
role for the membrane trafficking of caveolin-1. Knockdown of the Na/K-ATPase
leads to altered subcellular distribution of caveolin-1 and increases the
mobility of caveolin-1-containing vesicles
(16).Caveolin is a protein marker for caveolae
(17). Caveolae are
flask-shaped vesicular invaginations of plasma membrane and are enriched in
cholesterol, glycosphingolipids, and sphingomyelin
(18). There are three genes
and six isoforms of caveolin. Caveolin-1 is a 22-kDa protein and is expressed
in many types of cells, including epithelial and endothelial cells. In
addition to their role in biogenesis of caveolae
(19), accumulating evidence
has implicated caveolin proteins in cellular cholesterol homeostasis
(20). For instance, caveolin-1
directly binds to cholesterol in a 1:1 ratio
(21). It was also found to be
an integral member of the intracellular cholesterol trafficking machinery
between internal membranes and plasma membrane
(22,
23). The expression of
caveolin-1 appears to be under control of
SREBPs,2 the master
regulators of intracellular cholesterol level
(24). Furthermore, knockout of
caveolin-1 significantly affected cholesterol metabolism in mouse embryonic
fibroblasts and mouse peritoneal macrophages
(25). Because we found that
the Na/K-ATPase regulates cellular distribution of caveolin-1, we propose that
it may also affect intracellular cholesterol distribution and metabolism. To
test our hypothesis, we have investigated whether sodium pump α1
knockdown affects cholesterol distribution and metabolism both in
vitro and in vivo. Our results indicate that sodium pump
α1 expression level plays a role in the proper distribution of
intracellular cholesterol. Down-regulation of sodium pump α1 not only
redistributes cholesterol between the plasma membrane and cytosolic
compartments, but also alters cholesterol metabolism in mice. 相似文献
18.
Douglas A. Mitchell Shaun W. Lee Morgan A. Pence Andrew L. Markley Joyce D. Limm Victor Nizet Jack E. Dixon 《The Journal of biological chemistry》2009,284(19):13004-13012
The human pathogen Streptococcus pyogenes secretes a highly
cytolytic toxin known as streptolysin S (SLS). SLS is a key virulence
determinant and responsible for the β-hemolytic phenotype of these
bacteria. Despite over a century of research, the chemical structure of SLS
remains unknown. Recent experiments have revealed that SLS is generated from
an inactive precursor peptide that undergoes extensive post-translational
modification to an active form. In this work, we address outstanding questions
regarding the SLS biosynthetic process, elucidating the features of substrate
recognition and sites of posttranslational modification to the SLS precursor
peptide. Further, we exploit these findings to guide the design of artificial
cytolytic toxins that are recognized by the SLS biosynthetic enzymes and
others that are intrinsically cytolytic. This new structural information has
ramifications for future antimicrobial therapies.Streptolysin S
(SLS)4 is secreted by
the human pathogen Streptococcus pyogenes, the causative agent of
diseases ranging from pharyngitis to necrotizing fasciitis
(1). SLS is a potent cytolysin
that is ribosomally synthesized, extensively posttranslationally modified, and
exported to exert its effects on the target cell
(2,
3). The expression of SLS
promotes virulence in animal models of invasive infection and accounts for the
hall-mark zone of β-hemolysis surrounding colonies of these bacteria
grown on blood agar (2,
4). An intriguing feature of
SLS is its nonimmunogenic nature
(5). This characteristic is
likely due to its small size and its capacity to lyse cells involved in both
innate and adaptive immunity
(6,
7). The β-hemolytic
phenotype of S. pyogenes has been studied since the early 1900s, but
the molecular structure of SLS has remained elusive
(8). In the last decade,
transposon mutagenesis studies identified the gene encoding the SLS toxin
precursor (sagA, for SLS-associated gene) and eight additional genes
in an operon required for toxin maturation and export
(9). Targeted mutagenesis of
the sag operon yields nonhemolytic S. pyogenes mutants with
markedly diminished virulence in mice
(2). More recently, it was
demonstrated that the protein products of sagA–D are sufficient
for the in vitro reconstitution of cytolytic activity
(3). The first gene product,
SagA, serves as a structural template that after a series of tailoring
reactions matures into the active SLS metabolite (see
Fig. 1A). A trimeric
complex of SagBCD catalyzes these tailoring reactions, which results in the
conversion of cysteine, serine, and threonine residues to thiazole, oxazole,
and methyloxazole heterocycles, respectively
(3).Open in a separate windowFIGURE 1.SagBCD substrate recognition is provided by the SagA leader peptide.
A, SagA is converted into an active cytolysin, pro-streptolysin-S
(pro-SLS), by the actions of SagBCD (a trimeric oxazole/thiazole
synthetase). Heterocycles are schematically represented as shaded
pentagons. A marginally conserved motif in the SagA leader peptide,
FXXXB (where B is a branched chain amino acid), is highlighted in
red. Individual reactions catalyzed by SagC (cyclodehydratase) and
SagB (FMN-dehydrogenase) are shown. B, representative amino acid
sequences and cytolytic activity of SagA-like substrates. Shown in
red are leader peptide residues that comprise the FXXXB
motif. The putative leader peptide cleavage sites are shown as
asterisks, except for McbA, where the site is known
(hyphen). In blue are sites of potential heterocycle
formation (for McbA, known sites are blue). The percentage of amino
acid similarity to full-length SagA (as determined by ClustalW alignment) is
given. The cytolytic activity was tested for these substrates in
vitro using purified proteins and in vivo using the
SLS-deficient strain, S. pyogenes ΔsagA, complemented
with the desired substrate. Activity equal to wild type SagA is designated as
(+++); activity that is 30–70% of wild type SagA is (++); detectable
activity that is less than 30% of SagA is noted as (+); and nondetectable
activity is (-). The activity for McbA is not applicable (n.a.)
because this secondary metabolite is a DNA gyrase inhibitor, not a cytolysin.
C, sequences and lytic activity of mutant substrates. All of the
substrates contain the wild type SagA leader peptide, except for the first
entry (FXXXB mutant, SagA-FIA). The percentage of amino acid
similarity to the protoxin half of SagA is shown. The second and third entries
are SagA leader peptides fused to the protoxin of StaphA and ListA. SagX is an
artificially designed toxin, whereas the inverse and scrambled substrates
manipulate the sequence of SagA between residues 33–50
(underlined).A DNA gyrase inhibitor, microcin B17, is produced by an orthologous
biosynthetic cluster (mcb) found in a subset of Escherichia
coli strains
(10–12).
Microcin B17 contains four thiazole and four oxazole heterocycles, which are
indispensable for biological activity. By analogy to microcin B17 and the
lantibiotics, the heterocycles of SLS are formed on the C terminus of SagA,
whereas the N terminus serves as a leader peptide
(13–15).
The installation of thiazole and (methyl)-oxazole heterocycles restricts
backbone conformational flexibility and provides microcin B17 and SLS with
rigidified structures. The SLS heterocycles are formed via two distinct steps;
SagC, a cyclodehydratase, generates thiazoline and (methyl)-oxazoline
heterocycles, whereas SagB, a dehydrogenase, removes two electrons to afford
the aromatic thiazole and (methyl)-oxazole
(3,
16,
17). SagD is proposed to play
a role in trimer formation and regulation (see
Fig. 1A). The final
genes in the genetic cluster encode a predicted leader peptidase/immunity
protein (SagE), a membrane-associated protein of unknown function (SagF), and
three ABC transporters (SagGHI).It is now appreciated that many other prokaryotes harbor similar genetic
clusters for the synthesis of thiazole and (methyl)-oxazole heterocycles
(3,
18,
19). Additional important
mammalian pathogens such as Listeria monocytogenes, Staphylococcus
aureus, and Clostridium botulinum, contain sag-like
gene clusters that produce SLS-like cytolysins. These toxins are expected to
promote pathogen survival and host cell injury during infection, but this has
only been conclusively shown for S. pyogenes and L.
monocytogenes (2,
18). Like E. coli,
many other prokaryotes harbor a sag-like genetic cluster but are not
known to produce cytolysins. Some examples are the goadsporin-producing
organism, Streptomyces sp. TP-A0584 and cyanobactin producers such as
Prochloron didemni
(20–22).
The molecular targets of these secondary metabolites remain to be elucidated,
but it is known that goadsporin exhibits antibiotic activity, and the
cyanobactin, patellamide D, reverses multiple drug resistance in a human
leukemia cell line (23).
Because genetic loci containing sagBCD-like genes have been widely
disseminated in prokaryotes
(3), nature appears to have
found a preferred route to synthesizing such secondary metabolites.In this work, we build upon our initial report on the in vitro
reconstitution of SLS biosynthesis to uncover the requisite features of
substrate selectivity and cytolytic activity. The impetus for defining
substrate tolerance arose from earlier results showing that SagBCD accepts
alternate substrates in vitro
(3), as evidenced by two key
experiments. First, SagBCD converted a noncognate substrate, ClosA (C.
botulinum), into a cytolytic entity. Second, mass spectrometry revealed
heterocycle formation on the McbA (E. coli) peptide after SagBCD
treatment (3). Here, we dissect
the N-terminal leader peptide and C-terminal protoxin of SagA to define the
residues necessary for conversion into SLS. 相似文献
19.
Glucosinolates are plant secondary metabolites present in Brassicaceae
plants such as the model plant Arabidopsis thaliana. Intact
glucosinolates are believed to be biologically inactive, whereas degradation
products after hydrolysis have multiple roles in growth regulation and
defense. The degradation of glucosinolates is catalyzed by thioglucosidases
called myrosinases and leads by default to the formation of isothiocyanates.
The interaction of a protein called epithiospecifier protein (ESP) with
myrosinase diverts the reaction toward the production of epithionitriles or
nitriles depending on the glucosinolate structure. Here we report the
identification of a new group of nitrile-specifier proteins (AtNSPs) in A.
thaliana able to generate nitriles in conjunction with myrosinase and a
more detailed characterization of one member (AtNSP2). Recombinant AtNSP2
expressed in Escherichia coli was used to test its impact on the
outcome of glucosinolate hydrolysis using a gas chromatography-mass
spectrometry approach. AtNSP proteins share 30–45% sequence homology
with A. thaliana ESP. Although AtESP and AtNSP proteins can switch
myrosinase-catalyzed degradation of 2-propenylglucosinolate from
isothiocyanate to nitrile, only AtESP generates the corresponding
epithionitrile. Using the aromatic benzylglucosinolate, recombinant AtNSP2 is
also able to direct product formation to the nitrile. Analysis of
glucosinolate hydrolysis profiles of transgenic A. thaliana plants
overexpressing AtNSP2 confirms its nitrile-specifier activity in
planta. In silico expression analysis reveals distinctive
expression patterns of AtNSPs, which supports a biological role for these
proteins. In conclusion, we show that AtNSPs belonging to a new family of
A. thaliana proteins structurally related to AtESP divert product
formation from myrosinase-catalyzed glucosinolate hydrolysis and, thereby,
likely affect the biological consequences of glucosinolate degradation. We
discuss similarities and properties of AtNSPs and related proteins and the
biological implications.Brassicaceae plants such as oilseed rape (Brassica napus), turnip
(Brassica rapa), and white mustard (Sinapis alba) as well as
the model plant Arabidopsis thaliana contain a group of secondary
metabolites known as glucosinolates
(GSLs)2
(1,
2). These are
β-thioglucoside N-hydroxysulfates with a sulfur-linked
β-d-glucopyranose moiety and a variable side chain that is
derived from one of eight amino acids or their methylene group-elongated
derivatives. Aliphatic GSLs are derived from alanine, leucine, isoleucine,
valine, or predominantly methionine. Tyrosine or phenylalanine give aromatic
GSLs, and tryptophan-derived GSLs are called indolic GSLs (for review, see
Ref. 3). Although more than 120
different GSLs have been identified in total so far, individual plant species
usually contain only a few GSLs
(2). Quantitative and
qualitative differences of GSL profiles are also observed within a species,
such as, for example, for different A. thaliana ecotypes
(4–6).
In addition, GSL composition varies among organs and during the life cycle of
plants (7,
8) and is affected by external
factors (9).Intact GSLs are mostly considered to be biologically inactive. Most GSL
degradation products have toxic effects on insect, fungal, and bacterial
pests, serve as attractants for specialist insects, or may have beneficial
health effects for humans
(10–15).
The enzymatic degradation of GSLs (Fig.
1A), which occurs massively upon tissue damage, is
catalyzed by plant thioglucosidases called myrosinases (EC 3.2.1.147;
glycoside hydrolase family 1). Depending on several factors (e.g. GSL
structure, proteins, cofactors, pH) myrosinase-catalyzed hydrolysis of GSLs
can lead to a variety of products (Fig.
1B; for review, see Refs.
16 and
17). Of these, isothiocyanates
are the most common as their formation only requires myrosinase activity.
Thiocyanates on the other hand are only produced from a very limited number of
GSLs, and their formation necessitates the presence of a thiocyanate-forming
factor in addition to myrosinase
(18). A thiocyanate-forming
protein (TFP) has recently been identified in Lepidium sativum
(19). Alkenyl GSLs, a subgroup
of aliphatic GSLs containing a terminal unsaturation in their side chain, can
lead to the production of epithionitriles through the cooperative action of
myrosinase and a protein called epithiospecifier protein (ESP
(20)) in a ferrous
ion-dependent way
(21–23).
Both TFP and ESP contain a series of Kelch repeats
(19). Kelch repeats are
involved in protein-protein interactions, and Kelch repeat-containing proteins
are involved in a number of diverse biological processes
(24). In addition to
isothiocyanates, nitriles are the major group of GSL hydrolysis products.
Although ESP and TFP activities can generate nitriles
(19,
21,
25,
26), indications for an
ESP-independent nitrile-specifier activity exist. The GSL hydrolysis profile
of A. thaliana roots, an organ that does not show ESP expression or
activity (27), reveals
predominantly the presence of nitriles
(28). In addition, leaf tissue
of A. thaliana ecotypes supposedly devoid of ESP activity produces a
certain amount of nitriles upon autolysis
(21). Under acidic buffer
conditions, a non-enzymatic production of nitriles from GSLs is observed (Ref.
29 and references therein).
Increasing Fe2+ concentrations have also been shown to favor
nitrile formation over isothiocyanate formation from a number of GSLs in the
presence of myrosinase and absence of ESP
(21,
22). Therefore, a
non-enzymatic origin of this nitrile production cannot be excluded, although
the presence of a nitrile-specifier protein is a tempting alternative.
Although ESP is able to generate nitriles, it has also been shown that the
conversion rates of GSLs to nitriles are lower than those of GSLs to
epithionitriles for ESP (21,
22).Open in a separate windowFIGURE 1.Simplified scheme of enzymatic GSL hydrolysis (A) and
structures and names of GSLs and their hydrolysis products that are mentioned
in the article. (B). A, myrosinase acts on GSLs to form
an unstable aglycone intermediate that can rearrange spontaneously to form an
isothiocyanate. Hydrolysis can be diverted from this default route under
certain conditions (e.g. the presence of NSPs, ferrous ions, or at pH
< 5) to give the corresponding nitrile. ESP is responsible for the
formation of epithionitriles from alkenyl GSLs in a ferrous ion-dependent
mechanism. B, the general structure of GSLs, indicating the variable
side chain as R, is given as well as the three major classes of hydrolysis
products (i.e. isothiocyanates, nitriles, and epithionitriles). The
listed GSLs are the ones mentioned in this article and are arranged according
to the class of GSLs they belong to and with an increase in chain length or
complexity. The names of the respective hydrolysis products are given for a
better understanding of the present article, and not all were encountered
during our studies.A nitrile-specifier protein (NSP) that is able to redirect the hydrolysis
of GSLs toward nitriles has been cloned from the larvae of the butterfly
Pieris rapae (30).
This protein does not, however, exhibit sequence similarity to plant ESP, and
a corresponding plant nitrile-specifier protein has not yet been identified.
We report here the identification of a group of six A. thaliana genes
with some sequence similarity to A. thaliana ESP, providing evidence
for a new family of nitrile-specifier proteins and a more detailed
characterization of one member that possesses nitrile-specifier activity
in vitro, when applied exogenously to plant tissue and after ectopic
expression in the two A. thaliana ecotypes Col-0 and C24. Despite its
sequence homology to A. thaliana epithiospecifier protein (AtESP), it
does not possess epithiospecifier activity under similar conditions.
Therefore, we propose to designate this protein as A. thaliana
nitrile-specifier protein 2 (AtNSP2). Although the biological roles of AtNSP2
and related proteins are not yet known, their specificities and distinctive
expression patterns indicate the presence of a fine-tuned mechanism for GSL
degradation controlling the outcome of an array of biologically active
molecules. 相似文献